1 Study Coverage
    1.1 Intravenous (IV) Solution Product Introduction
    1.2 Market by Type
        1.2.1 Global Intravenous (IV) Solution Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Total Parenteral Solution
        1.2.3 Peripheral Parenteral Solution
    1.3 Market by Application
        1.3.1 Global Intravenous (IV) Solution Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospitals & Clinics
        1.3.3 Ambulatory
        1.3.4 Homecare
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Intravenous (IV) Solution Sales Estimates and Forecasts 2017-2028
    2.2 Global Intravenous (IV) Solution Revenue Estimates and Forecasts 2017-2028
    2.3 Global Intravenous (IV) Solution Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Intravenous (IV) Solution Sales by Region
        2.4.1 Global Intravenous (IV) Solution Sales by Region (2017-2022)
        2.4.2 Global Sales Intravenous (IV) Solution by Region (2023-2028)
    2.5 Global Intravenous (IV) Solution Revenue by Region
        2.5.1 Global Intravenous (IV) Solution Revenue by Region (2017-2022)
        2.5.2 Global Intravenous (IV) Solution Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Intravenous (IV) Solution Sales by Manufacturers
        3.1.1 Global Top Intravenous (IV) Solution Manufacturers by Sales (2017-2022)
        3.1.2 Global Intravenous (IV) Solution Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Intravenous (IV) Solution in 2021
    3.2 Global Intravenous (IV) Solution Revenue by Manufacturers
        3.2.1 Global Intravenous (IV) Solution Revenue by Manufacturers (2017-2022)
        3.2.2 Global Intravenous (IV) Solution Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Intravenous (IV) Solution Revenue in 2021
    3.3 Global Intravenous (IV) Solution Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Intravenous (IV) Solution Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Intravenous (IV) Solution Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Intravenous (IV) Solution Sales by Type
        4.1.1 Global Intravenous (IV) Solution Historical Sales by Type (2017-2022)
        4.1.2 Global Intravenous (IV) Solution Forecasted Sales by Type (2023-2028)
        4.1.3 Global Intravenous (IV) Solution Sales Market Share by Type (2017-2028)
    4.2 Global Intravenous (IV) Solution Revenue by Type
        4.2.1 Global Intravenous (IV) Solution Historical Revenue by Type (2017-2022)
        4.2.2 Global Intravenous (IV) Solution Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Intravenous (IV) Solution Revenue Market Share by Type (2017-2028)
    4.3 Global Intravenous (IV) Solution Price by Type
        4.3.1 Global Intravenous (IV) Solution Price by Type (2017-2022)
        4.3.2 Global Intravenous (IV) Solution Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Intravenous (IV) Solution Sales by Application
        5.1.1 Global Intravenous (IV) Solution Historical Sales by Application (2017-2022)
        5.1.2 Global Intravenous (IV) Solution Forecasted Sales by Application (2023-2028)
        5.1.3 Global Intravenous (IV) Solution Sales Market Share by Application (2017-2028)
    5.2 Global Intravenous (IV) Solution Revenue by Application
        5.2.1 Global Intravenous (IV) Solution Historical Revenue by Application (2017-2022)
        5.2.2 Global Intravenous (IV) Solution Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Intravenous (IV) Solution Revenue Market Share by Application (2017-2028)
    5.3 Global Intravenous (IV) Solution Price by Application
        5.3.1 Global Intravenous (IV) Solution Price by Application (2017-2022)
        5.3.2 Global Intravenous (IV) Solution Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Intravenous (IV) Solution Market Size by Type
        6.1.1 North America Intravenous (IV) Solution Sales by Type (2017-2028)
        6.1.2 North America Intravenous (IV) Solution Revenue by Type (2017-2028)
    6.2 North America Intravenous (IV) Solution Market Size by Application
        6.2.1 North America Intravenous (IV) Solution Sales by Application (2017-2028)
        6.2.2 North America Intravenous (IV) Solution Revenue by Application (2017-2028)
    6.3 North America Intravenous (IV) Solution Market Size by Country
        6.3.1 North America Intravenous (IV) Solution Sales by Country (2017-2028)
        6.3.2 North America Intravenous (IV) Solution Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Intravenous (IV) Solution Market Size by Type
        7.1.1 Europe Intravenous (IV) Solution Sales by Type (2017-2028)
        7.1.2 Europe Intravenous (IV) Solution Revenue by Type (2017-2028)
    7.2 Europe Intravenous (IV) Solution Market Size by Application
        7.2.1 Europe Intravenous (IV) Solution Sales by Application (2017-2028)
        7.2.2 Europe Intravenous (IV) Solution Revenue by Application (2017-2028)
    7.3 Europe Intravenous (IV) Solution Market Size by Country
        7.3.1 Europe Intravenous (IV) Solution Sales by Country (2017-2028)
        7.3.2 Europe Intravenous (IV) Solution Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Intravenous (IV) Solution Market Size by Type
        8.1.1 Asia Pacific Intravenous (IV) Solution Sales by Type (2017-2028)
        8.1.2 Asia Pacific Intravenous (IV) Solution Revenue by Type (2017-2028)
    8.2 Asia Pacific Intravenous (IV) Solution Market Size by Application
        8.2.1 Asia Pacific Intravenous (IV) Solution Sales by Application (2017-2028)
        8.2.2 Asia Pacific Intravenous (IV) Solution Revenue by Application (2017-2028)
    8.3 Asia Pacific Intravenous (IV) Solution Market Size by Region
        8.3.1 Asia Pacific Intravenous (IV) Solution Sales by Region (2017-2028)
        8.3.2 Asia Pacific Intravenous (IV) Solution Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Intravenous (IV) Solution Market Size by Type
        9.1.1 Latin America Intravenous (IV) Solution Sales by Type (2017-2028)
        9.1.2 Latin America Intravenous (IV) Solution Revenue by Type (2017-2028)
    9.2 Latin America Intravenous (IV) Solution Market Size by Application
        9.2.1 Latin America Intravenous (IV) Solution Sales by Application (2017-2028)
        9.2.2 Latin America Intravenous (IV) Solution Revenue by Application (2017-2028)
    9.3 Latin America Intravenous (IV) Solution Market Size by Country
        9.3.1 Latin America Intravenous (IV) Solution Sales by Country (2017-2028)
        9.3.2 Latin America Intravenous (IV) Solution Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Intravenous (IV) Solution Market Size by Type
        10.1.1 Middle East and Africa Intravenous (IV) Solution Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Intravenous (IV) Solution Revenue by Type (2017-2028)
    10.2 Middle East and Africa Intravenous (IV) Solution Market Size by Application
        10.2.1 Middle East and Africa Intravenous (IV) Solution Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Intravenous (IV) Solution Revenue by Application (2017-2028)
    10.3 Middle East and Africa Intravenous (IV) Solution Market Size by Country
        10.3.1 Middle East and Africa Intravenous (IV) Solution Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Intravenous (IV) Solution Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 ICU Medical
        11.1.1 ICU Medical Corporation Information
        11.1.2 ICU Medical Overview
        11.1.3 ICU Medical Intravenous (IV) Solution Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 ICU Medical Intravenous (IV) Solution Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 ICU Medical Recent Developments
    11.2 B. Braun Melsungen
        11.2.1 B. Braun Melsungen Corporation Information
        11.2.2 B. Braun Melsungen Overview
        11.2.3 B. Braun Melsungen Intravenous (IV) Solution Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 B. Braun Melsungen Intravenous (IV) Solution Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 B. Braun Melsungen Recent Developments
    11.3 Fresenius Kabi
        11.3.1 Fresenius Kabi Corporation Information
        11.3.2 Fresenius Kabi Overview
        11.3.3 Fresenius Kabi Intravenous (IV) Solution Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Fresenius Kabi Intravenous (IV) Solution Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Fresenius Kabi Recent Developments
    11.4 Baxter
        11.4.1 Baxter Corporation Information
        11.4.2 Baxter Overview
        11.4.3 Baxter Intravenous (IV) Solution Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Baxter Intravenous (IV) Solution Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Baxter Recent Developments
    11.5 Amanta Healthcare
        11.5.1 Amanta Healthcare Corporation Information
        11.5.2 Amanta Healthcare Overview
        11.5.3 Amanta Healthcare Intravenous (IV) Solution Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Amanta Healthcare Intravenous (IV) Solution Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Amanta Healthcare Recent Developments
    11.6 Terumo Medical
        11.6.1 Terumo Medical Corporation Information
        11.6.2 Terumo Medical Overview
        11.6.3 Terumo Medical Intravenous (IV) Solution Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Terumo Medical Intravenous (IV) Solution Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Terumo Medical Recent Developments
    11.7 Grifols
        11.7.1 Grifols Corporation Information
        11.7.2 Grifols Overview
        11.7.3 Grifols Intravenous (IV) Solution Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Grifols Intravenous (IV) Solution Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Grifols Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Intravenous (IV) Solution Industry Chain Analysis
    12.2 Intravenous (IV) Solution Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Intravenous (IV) Solution Production Mode & Process
    12.4 Intravenous (IV) Solution Sales and Marketing
        12.4.1 Intravenous (IV) Solution Sales Channels
        12.4.2 Intravenous (IV) Solution Distributors
    12.5 Intravenous (IV) Solution Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Intravenous (IV) Solution Industry Trends
    13.2 Intravenous (IV) Solution Market Drivers
    13.3 Intravenous (IV) Solution Market Challenges
    13.4 Intravenous (IV) Solution Market Restraints
14 Key Findings in The Global Intravenous (IV) Solution Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Intravenous (IV) Solution Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Total Parenteral Solution
    Table 3. Major Manufacturers of Peripheral Parenteral Solution
    Table 4. Global Intravenous (IV) Solution Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 5. Global Intravenous (IV) Solution Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Intravenous (IV) Solution Sales by Region (2017-2022) & (K Units)
    Table 7. Global Intravenous (IV) Solution Sales Market Share by Region (2017-2022)
    Table 8. Global Intravenous (IV) Solution Sales by Region (2023-2028) & (K Units)
    Table 9. Global Intravenous (IV) Solution Sales Market Share by Region (2023-2028)
    Table 10. Global Intravenous (IV) Solution Revenue by Region (2017-2022) & (US$ Million)
    Table 11. Global Intravenous (IV) Solution Revenue Market Share by Region (2017-2022)
    Table 12. Global Intravenous (IV) Solution Revenue by Region (2023-2028) & (US$ Million)
    Table 13. Global Intravenous (IV) Solution Revenue Market Share by Region (2023-2028)
    Table 14. Global Intravenous (IV) Solution Sales by Manufacturers (2017-2022) & (K Units)
    Table 15. Global Intravenous (IV) Solution Sales Share by Manufacturers (2017-2022)
    Table 16. Global Intravenous (IV) Solution Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 17. Global Intravenous (IV) Solution Revenue Share by Manufacturers (2017-2022)
    Table 18. Intravenous (IV) Solution Price by Manufacturers (2017-2022) &(USD/Unit)
    Table 19. Global Intravenous (IV) Solution Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 20. Global Intravenous (IV) Solution by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intravenous (IV) Solution as of 2021)
    Table 21. Intravenous (IV) Solution Manufacturing Base Distribution and Headquarters
    Table 22. Manufacturers Intravenous (IV) Solution Product Offered
    Table 23. Date of Manufacturers Enter into Intravenous (IV) Solution Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Intravenous (IV) Solution Sales by Type (2017-2022) & (K Units)
    Table 26. Global Intravenous (IV) Solution Sales by Type (2023-2028) & (K Units)
    Table 27. Global Intravenous (IV) Solution Sales Share by Type (2017-2022)
    Table 28. Global Intravenous (IV) Solution Sales Share by Type (2023-2028)
    Table 29. Global Intravenous (IV) Solution Revenue by Type (2017-2022) & (US$ Million)
    Table 30. Global Intravenous (IV) Solution Revenue by Type (2023-2028) & (US$ Million)
    Table 31. Global Intravenous (IV) Solution Revenue Share by Type (2017-2022)
    Table 32. Global Intravenous (IV) Solution Revenue Share by Type (2023-2028)
    Table 33. Intravenous (IV) Solution Price by Type (2017-2022) & (USD/Unit)
    Table 34. Global Intravenous (IV) Solution Price Forecast by Type (2023-2028) & (USD/Unit)
    Table 35. Global Intravenous (IV) Solution Sales by Application (2017-2022) & (K Units)
    Table 36. Global Intravenous (IV) Solution Sales by Application (2023-2028) & (K Units)
    Table 37. Global Intravenous (IV) Solution Sales Share by Application (2017-2022)
    Table 38. Global Intravenous (IV) Solution Sales Share by Application (2023-2028)
    Table 39. Global Intravenous (IV) Solution Revenue by Application (2017-2022) & (US$ Million)
    Table 40. Global Intravenous (IV) Solution Revenue by Application (2023-2028) & (US$ Million)
    Table 41. Global Intravenous (IV) Solution Revenue Share by Application (2017-2022)
    Table 42. Global Intravenous (IV) Solution Revenue Share by Application (2023-2028)
    Table 43. Intravenous (IV) Solution Price by Application (2017-2022) & (USD/Unit)
    Table 44. Global Intravenous (IV) Solution Price Forecast by Application (2023-2028) & (USD/Unit)
    Table 45. North America Intravenous (IV) Solution Sales by Type (2017-2022) & (K Units)
    Table 46. North America Intravenous (IV) Solution Sales by Type (2023-2028) & (K Units)
    Table 47. North America Intravenous (IV) Solution Revenue by Type (2017-2022) & (US$ Million)
    Table 48. North America Intravenous (IV) Solution Revenue by Type (2023-2028) & (US$ Million)
    Table 49. North America Intravenous (IV) Solution Sales by Application (2017-2022) & (K Units)
    Table 50. North America Intravenous (IV) Solution Sales by Application (2023-2028) & (K Units)
    Table 51. North America Intravenous (IV) Solution Revenue by Application (2017-2022) & (US$ Million)
    Table 52. North America Intravenous (IV) Solution Revenue by Application (2023-2028) & (US$ Million)
    Table 53. North America Intravenous (IV) Solution Sales by Country (2017-2022) & (K Units)
    Table 54. North America Intravenous (IV) Solution Sales by Country (2023-2028) & (K Units)
    Table 55. North America Intravenous (IV) Solution Revenue by Country (2017-2022) & (US$ Million)
    Table 56. North America Intravenous (IV) Solution Revenue by Country (2023-2028) & (US$ Million)
    Table 57. Europe Intravenous (IV) Solution Sales by Type (2017-2022) & (K Units)
    Table 58. Europe Intravenous (IV) Solution Sales by Type (2023-2028) & (K Units)
    Table 59. Europe Intravenous (IV) Solution Revenue by Type (2017-2022) & (US$ Million)
    Table 60. Europe Intravenous (IV) Solution Revenue by Type (2023-2028) & (US$ Million)
    Table 61. Europe Intravenous (IV) Solution Sales by Application (2017-2022) & (K Units)
    Table 62. Europe Intravenous (IV) Solution Sales by Application (2023-2028) & (K Units)
    Table 63. Europe Intravenous (IV) Solution Revenue by Application (2017-2022) & (US$ Million)
    Table 64. Europe Intravenous (IV) Solution Revenue by Application (2023-2028) & (US$ Million)
    Table 65. Europe Intravenous (IV) Solution Sales by Country (2017-2022) & (K Units)
    Table 66. Europe Intravenous (IV) Solution Sales by Country (2023-2028) & (K Units)
    Table 67. Europe Intravenous (IV) Solution Revenue by Country (2017-2022) & (US$ Million)
    Table 68. Europe Intravenous (IV) Solution Revenue by Country (2023-2028) & (US$ Million)
    Table 69. Asia Pacific Intravenous (IV) Solution Sales by Type (2017-2022) & (K Units)
    Table 70. Asia Pacific Intravenous (IV) Solution Sales by Type (2023-2028) & (K Units)
    Table 71. Asia Pacific Intravenous (IV) Solution Revenue by Type (2017-2022) & (US$ Million)
    Table 72. Asia Pacific Intravenous (IV) Solution Revenue by Type (2023-2028) & (US$ Million)
    Table 73. Asia Pacific Intravenous (IV) Solution Sales by Application (2017-2022) & (K Units)
    Table 74. Asia Pacific Intravenous (IV) Solution Sales by Application (2023-2028) & (K Units)
    Table 75. Asia Pacific Intravenous (IV) Solution Revenue by Application (2017-2022) & (US$ Million)
    Table 76. Asia Pacific Intravenous (IV) Solution Revenue by Application (2023-2028) & (US$ Million)
    Table 77. Asia Pacific Intravenous (IV) Solution Sales by Region (2017-2022) & (K Units)
    Table 78. Asia Pacific Intravenous (IV) Solution Sales by Region (2023-2028) & (K Units)
    Table 79. Asia Pacific Intravenous (IV) Solution Revenue by Region (2017-2022) & (US$ Million)
    Table 80. Asia Pacific Intravenous (IV) Solution Revenue by Region (2023-2028) & (US$ Million)
    Table 81. Latin America Intravenous (IV) Solution Sales by Type (2017-2022) & (K Units)
    Table 82. Latin America Intravenous (IV) Solution Sales by Type (2023-2028) & (K Units)
    Table 83. Latin America Intravenous (IV) Solution Revenue by Type (2017-2022) & (US$ Million)
    Table 84. Latin America Intravenous (IV) Solution Revenue by Type (2023-2028) & (US$ Million)
    Table 85. Latin America Intravenous (IV) Solution Sales by Application (2017-2022) & (K Units)
    Table 86. Latin America Intravenous (IV) Solution Sales by Application (2023-2028) & (K Units)
    Table 87. Latin America Intravenous (IV) Solution Revenue by Application (2017-2022) & (US$ Million)
    Table 88. Latin America Intravenous (IV) Solution Revenue by Application (2023-2028) & (US$ Million)
    Table 89. Latin America Intravenous (IV) Solution Sales by Country (2017-2022) & (K Units)
    Table 90. Latin America Intravenous (IV) Solution Sales by Country (2023-2028) & (K Units)
    Table 91. Latin America Intravenous (IV) Solution Revenue by Country (2017-2022) & (US$ Million)
    Table 92. Latin America Intravenous (IV) Solution Revenue by Country (2023-2028) & (US$ Million)
    Table 93. Middle East and Africa Intravenous (IV) Solution Sales by Type (2017-2022) & (K Units)
    Table 94. Middle East and Africa Intravenous (IV) Solution Sales by Type (2023-2028) & (K Units)
    Table 95. Middle East and Africa Intravenous (IV) Solution Revenue by Type (2017-2022) & (US$ Million)
    Table 96. Middle East and Africa Intravenous (IV) Solution Revenue by Type (2023-2028) & (US$ Million)
    Table 97. Middle East and Africa Intravenous (IV) Solution Sales by Application (2017-2022) & (K Units)
    Table 98. Middle East and Africa Intravenous (IV) Solution Sales by Application (2023-2028) & (K Units)
    Table 99. Middle East and Africa Intravenous (IV) Solution Revenue by Application (2017-2022) & (US$ Million)
    Table 100. Middle East and Africa Intravenous (IV) Solution Revenue by Application (2023-2028) & (US$ Million)
    Table 101. Middle East and Africa Intravenous (IV) Solution Sales by Country (2017-2022) & (K Units)
    Table 102. Middle East and Africa Intravenous (IV) Solution Sales by Country (2023-2028) & (K Units)
    Table 103. Middle East and Africa Intravenous (IV) Solution Revenue by Country (2017-2022) & (US$ Million)
    Table 104. Middle East and Africa Intravenous (IV) Solution Revenue by Country (2023-2028) & (US$ Million)
    Table 105. ICU Medical Corporation Information
    Table 106. ICU Medical Description and Major Businesses
    Table 107. ICU Medical Intravenous (IV) Solution Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 108. ICU Medical Intravenous (IV) Solution Product Model Numbers, Pictures, Descriptions and Specifications
    Table 109. ICU Medical Recent Developments
    Table 110. B. Braun Melsungen Corporation Information
    Table 111. B. Braun Melsungen Description and Major Businesses
    Table 112. B. Braun Melsungen Intravenous (IV) Solution Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 113. B. Braun Melsungen Intravenous (IV) Solution Product Model Numbers, Pictures, Descriptions and Specifications
    Table 114. B. Braun Melsungen Recent Developments
    Table 115. Fresenius Kabi Corporation Information
    Table 116. Fresenius Kabi Description and Major Businesses
    Table 117. Fresenius Kabi Intravenous (IV) Solution Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 118. Fresenius Kabi Intravenous (IV) Solution Product Model Numbers, Pictures, Descriptions and Specifications
    Table 119. Fresenius Kabi Recent Developments
    Table 120. Baxter Corporation Information
    Table 121. Baxter Description and Major Businesses
    Table 122. Baxter Intravenous (IV) Solution Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 123. Baxter Intravenous (IV) Solution Product Model Numbers, Pictures, Descriptions and Specifications
    Table 124. Baxter Recent Developments
    Table 125. Amanta Healthcare Corporation Information
    Table 126. Amanta Healthcare Description and Major Businesses
    Table 127. Amanta Healthcare Intravenous (IV) Solution Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 128. Amanta Healthcare Intravenous (IV) Solution Product Model Numbers, Pictures, Descriptions and Specifications
    Table 129. Amanta Healthcare Recent Developments
    Table 130. Terumo Medical Corporation Information
    Table 131. Terumo Medical Description and Major Businesses
    Table 132. Terumo Medical Intravenous (IV) Solution Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 133. Terumo Medical Intravenous (IV) Solution Product Model Numbers, Pictures, Descriptions and Specifications
    Table 134. Terumo Medical Recent Developments
    Table 135. Grifols Corporation Information
    Table 136. Grifols Description and Major Businesses
    Table 137. Grifols Intravenous (IV) Solution Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 138. Grifols Intravenous (IV) Solution Product Model Numbers, Pictures, Descriptions and Specifications
    Table 139. Grifols Recent Developments
    Table 140. Key Raw Materials Lists
    Table 141. Raw Materials Key Suppliers Lists
    Table 142. Intravenous (IV) Solution Distributors List
    Table 143. Intravenous (IV) Solution Customers List
    Table 144. Intravenous (IV) Solution Market Trends
    Table 145. Intravenous (IV) Solution Market Drivers
    Table 146. Intravenous (IV) Solution Market Challenges
    Table 147. Intravenous (IV) Solution Market Restraints
    Table 148. Research Programs/Design for This Report
    Table 149. Key Data Information from Secondary Sources
    Table 150. Key Data Information from Primary Sources
List of Figures
    Figure 1. Intravenous (IV) Solution Product Picture
    Figure 3. Global Intravenous (IV) Solution Market Share by Type in 2021 & 2028
    Figure 3. Total Parenteral Solution Product Picture
    Figure 4. Peripheral Parenteral Solution Product Picture
    Figure 5. Global Intravenous (IV) Solution Market Share by Application in 2021 & 2028
    Figure 6. Hospitals & Clinics
    Figure 7. Ambulatory
    Figure 8. Homecare
    Figure 9. Intravenous (IV) Solution Report Years Considered
    Figure 10. Global Intravenous (IV) Solution Sales 2017-2028 (K Units)
    Figure 11. Global Intravenous (IV) Solution Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Intravenous (IV) Solution Revenue 2017-2028 (US$ Million)
    Figure 13. Global Intravenous (IV) Solution Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 14. Global Intravenous (IV) Solution Sales Market Share by Region (2017-2022)
    Figure 15. Global Intravenous (IV) Solution Sales Market Share by Region (2023-2028)
    Figure 16. North America Intravenous (IV) Solution Sales YoY (2017-2028) & (K Units)
    Figure 17. North America Intravenous (IV) Solution Revenue YoY (2017-2028) & (US$ Million)
    Figure 18. Europe Intravenous (IV) Solution Sales YoY (2017-2028) & (K Units)
    Figure 19. Europe Intravenous (IV) Solution Revenue YoY (2017-2028) & (US$ Million)
    Figure 20. Asia-Pacific Intravenous (IV) Solution Sales YoY (2017-2028) & (K Units)
    Figure 21. Asia-Pacific Intravenous (IV) Solution Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Latin America Intravenous (IV) Solution Sales YoY (2017-2028) & (K Units)
    Figure 23. Latin America Intravenous (IV) Solution Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Middle East & Africa Intravenous (IV) Solution Sales YoY (2017-2028) & (K Units)
    Figure 25. Middle East & Africa Intravenous (IV) Solution Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. The Intravenous (IV) Solution Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 27. The Top 5 and 10 Largest Manufacturers of Intravenous (IV) Solution in the World: Market Share by Intravenous (IV) Solution Revenue in 2021
    Figure 28. Global Intravenous (IV) Solution Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 29. Global Intravenous (IV) Solution Sales Market Share by Type (2017-2028)
    Figure 30. Global Intravenous (IV) Solution Revenue Market Share by Type (2017-2028)
    Figure 31. Global Intravenous (IV) Solution Sales Market Share by Application (2017-2028)
    Figure 32. Global Intravenous (IV) Solution Revenue Market Share by Application (2017-2028)
    Figure 33. North America Intravenous (IV) Solution Sales Market Share by Type (2017-2028)
    Figure 34. North America Intravenous (IV) Solution Revenue Market Share by Type (2017-2028)
    Figure 35. North America Intravenous (IV) Solution Sales Market Share by Application (2017-2028)
    Figure 36. North America Intravenous (IV) Solution Revenue Market Share by Application (2017-2028)
    Figure 37. North America Intravenous (IV) Solution Sales Share by Country (2017-2028)
    Figure 38. North America Intravenous (IV) Solution Revenue Share by Country (2017-2028)
    Figure 39. U.S. Intravenous (IV) Solution Revenue (2017-2028) & (US$ Million)
    Figure 40. Canada Intravenous (IV) Solution Revenue (2017-2028) & (US$ Million)
    Figure 41. Europe Intravenous (IV) Solution Sales Market Share by Type (2017-2028)
    Figure 42. Europe Intravenous (IV) Solution Revenue Market Share by Type (2017-2028)
    Figure 43. Europe Intravenous (IV) Solution Sales Market Share by Application (2017-2028)
    Figure 44. Europe Intravenous (IV) Solution Revenue Market Share by Application (2017-2028)
    Figure 45. Europe Intravenous (IV) Solution Sales Share by Country (2017-2028)
    Figure 46. Europe Intravenous (IV) Solution Revenue Share by Country (2017-2028)
    Figure 47. Germany Intravenous (IV) Solution Revenue (2017-2028) & (US$ Million)
    Figure 48. France Intravenous (IV) Solution Revenue (2017-2028) & (US$ Million)
    Figure 49. U.K. Intravenous (IV) Solution Revenue (2017-2028) & (US$ Million)
    Figure 50. Italy Intravenous (IV) Solution Revenue (2017-2028) & (US$ Million)
    Figure 51. Russia Intravenous (IV) Solution Revenue (2017-2028) & (US$ Million)
    Figure 52. Asia Pacific Intravenous (IV) Solution Sales Market Share by Type (2017-2028)
    Figure 53. Asia Pacific Intravenous (IV) Solution Revenue Market Share by Type (2017-2028)
    Figure 54. Asia Pacific Intravenous (IV) Solution Sales Market Share by Application (2017-2028)
    Figure 55. Asia Pacific Intravenous (IV) Solution Revenue Market Share by Application (2017-2028)
    Figure 56. Asia Pacific Intravenous (IV) Solution Sales Share by Region (2017-2028)
    Figure 57. Asia Pacific Intravenous (IV) Solution Revenue Share by Region (2017-2028)
    Figure 58. China Intravenous (IV) Solution Revenue (2017-2028) & (US$ Million)
    Figure 59. Japan Intravenous (IV) Solution Revenue (2017-2028) & (US$ Million)
    Figure 60. South Korea Intravenous (IV) Solution Revenue (2017-2028) & (US$ Million)
    Figure 61. India Intravenous (IV) Solution Revenue (2017-2028) & (US$ Million)
    Figure 62. Australia Intravenous (IV) Solution Revenue (2017-2028) & (US$ Million)
    Figure 63. Taiwan Intravenous (IV) Solution Revenue (2017-2028) & (US$ Million)
    Figure 64. Indonesia Intravenous (IV) Solution Revenue (2017-2028) & (US$ Million)
    Figure 65. Thailand Intravenous (IV) Solution Revenue (2017-2028) & (US$ Million)
    Figure 66. Malaysia Intravenous (IV) Solution Revenue (2017-2028) & (US$ Million)
    Figure 67. Philippines Intravenous (IV) Solution Revenue (2017-2028) & (US$ Million)
    Figure 68. Latin America Intravenous (IV) Solution Sales Market Share by Type (2017-2028)
    Figure 69. Latin America Intravenous (IV) Solution Revenue Market Share by Type (2017-2028)
    Figure 70. Latin America Intravenous (IV) Solution Sales Market Share by Application (2017-2028)
    Figure 71. Latin America Intravenous (IV) Solution Revenue Market Share by Application (2017-2028)
    Figure 72. Latin America Intravenous (IV) Solution Sales Share by Country (2017-2028)
    Figure 73. Latin America Intravenous (IV) Solution Revenue Share by Country (2017-2028)
    Figure 74. Mexico Intravenous (IV) Solution Revenue (2017-2028) & (US$ Million)
    Figure 75. Brazil Intravenous (IV) Solution Revenue (2017-2028) & (US$ Million)
    Figure 76. Argentina Intravenous (IV) Solution Revenue (2017-2028) & (US$ Million)
    Figure 77. Middle East and Africa Intravenous (IV) Solution Sales Market Share by Type (2017-2028)
    Figure 78. Middle East and Africa Intravenous (IV) Solution Revenue Market Share by Type (2017-2028)
    Figure 79. Middle East and Africa Intravenous (IV) Solution Sales Market Share by Application (2017-2028)
    Figure 80. Middle East and Africa Intravenous (IV) Solution Revenue Market Share by Application (2017-2028)
    Figure 81. Middle East and Africa Intravenous (IV) Solution Sales Share by Country (2017-2028)
    Figure 82. Middle East and Africa Intravenous (IV) Solution Revenue Share by Country (2017-2028)
    Figure 83. Turkey Intravenous (IV) Solution Revenue (2017-2028) & (US$ Million)
    Figure 84. Saudi Arabia Intravenous (IV) Solution Revenue (2017-2028) & (US$ Million)
    Figure 85. U.A.E Intravenous (IV) Solution Revenue (2017-2028) & (US$ Million)
    Figure 86. Intravenous (IV) Solution Value Chain
    Figure 87. Intravenous (IV) Solution Production Process
    Figure 88. Channels of Distribution
    Figure 89. Distributors Profiles
    Figure 90. Bottom-up and Top-down Approaches for This Report
    Figure 91. Data Triangulation
    Figure 92. Key Executives Interviewed